Clinical Sciences Flashcards
HLA B27?
Ankylosing spondylitis Postgonococcal arthritis Acute anterior uveitis Reiter’s syndrome (reactive arthritis)
HLA-DR2?
Narcolepsy
Goodpasture’s
(2 good 2 sleepy)
HLA DR3?
Autoimmune hepatitis
Primary biliary cirrhosis
Diabetes mellitus type 1
Dermatitis herpetiformis
Coeliac disease (95% associated with HLA-DQ2)
Primary Sjögren syndrome
HLA DR4?
Rheumatoid arthritis
Diabetes mellitus type 1 (> DR3)
(4 fingers, BM 4)
HLA B47?
21-hydroxylase deficiency
(47 is life expectancy)
HLA A3?
Hemochromatosis
Iron overload –> overloaded –> think cardiology, ward A3
HLA-B5?
Bechet’s disease
B –> Bechet’s
Clusters of differentiation? (CD molecules)
Type I Hypersensitivity Reaction?
Anaphylactic
- Antigen reacts with IgE bound to mast cells
- Anaphylaxis, atopy
Type II Hypersensitivity?
Cell Bound
- IgG or IgM bind to antigen on cell surface
- Autoimmune haemolytic anaemia, ITP, Goodpasture’s
Type III Hypersensitivity Reaction?
Immune Complex
- Free antigen and antibody (IgG, IgA) combine
- Serum sickness, SLE, post-streptococcal glomerulonephritis, extrinsic allergic alveolitis
Type IV Hypersensitivity?
Delayed Hypersensitivity
- T-cell mediated
- TB, Tuberculin skin reaction, graft vs host disease, contact dermatitis, scabies, extrinsci allergic alveolitis (chronic phase)
Think Ts
Type V hypersensitivity reaction?
Stimulated Hypersensitivity
- IgG antiboides stimulate cells they are directed against
- Grave’s, Myasthenia Gravis
IgG?
- IgG makes up approximately 75% of the serum antibodies.
- IgG has a half-life of 7-23 days depending on the subclass.
- IgG is a monomer and has 2 epitope-binding sites
- The Fc portion of IgG can activate the classical complement pathway.
- The Fc portion of IgG can bind to macrophage and neutrophils for enhanced phaGocytosis.
- The Fc portion of IgG can bind to NK cells for antibody-dependent cytotoxicity (ADCC).
- The Fc portion of IgG enables it to cross the placenta. (IgG is the only class of antibody that
can cross the placenta and enter the fetal circulation).
IgA?
- IgA makes up approximately 15% of the serum antibodies, it has a half-life of aound 5 days.
- IgA is found mainly in body secretions (saliva, mucous, tears, colostrum and milk) as secretory IgA (sIgA) where it protects internal body surfaces exposed to the environment by blocking the attachment of bacteria and viruses to mucous membranes.
- Secretory IgA is the most immunoglobulin produced.
- IgA is made primarily in the mucosal-associated lymphoid tissues (MALT).
- IgA appears as a dimer of 2 “Y”-shaped molecules and has 4 epitope-binding sites and secretory component to protect it from digestive enzymes in the secretions
- The Fc portion of secretory IgA binds to components of mucous and contributes to the ability of mucous to trap microbes.
- IgA can activate the alternative complement pathway. (IgA = Alternate)
IgM?
- IgM makes up approximately 10% of the serum antibodies and is the first antibody produced
during an immune response. - IgM has a half-life of about 5 days.
- IgM is a pentamer and has 10 epitope-binding sites
- The Fc portions of IgM are able to activate the classical complement pathway (most efficient)
- Monomeric forms of IgM are found on the surface of B-lymphocytes as B-cell receptors or sIg.
IgD?
- IgD makes up approximately 1% of the serum antibodies.
- IgD is a monomer and has 2 epitope-binding sites.
- IgD is found on the surface of B-lymphocytes (along with monomeric IgM) as a B-cell receptor or sIg where it may control of B-lymphocyte activation and suppression.
- IgD may play a role in eliminating B-lymphocytes generating self-reactive autoantibodies.
IgE?
- IgE makes up about 0.002% of the serum antibodies with a half-life of 2 days.
- Most IgE is tightly bound to basophils and mast cells via its Fc region.
- IgE is a monomer and has 2 epitope-binding sites.
- IgE is made in response to parasitic worms (helminths) and arthropods. It is also often made in
response to allergens. - IgE may protect external mucosal surfaces by promoting inflammation, enabling IgG,
complement proteins, and leucocytes to enter the tissues. - The Fc portion of IgE can bind to mast cells and basophils where it mediates many allergic
reactions. Cross linking of cell-bound IgE by antigen triggers the release of vasodilators for an
inflammatory response. - The Fc portion of IgE made against parasitic worms and arthropods can bind to
eosinophils enabling opsonization. This is a major defense against parasitic worms and
arthropods.
Most common targets of pANCA and cANCA?
cANCA
- Serine protease 3 (PR3)
- Wegener’s +ve in 90%
pANCA
- Myeloperoxidase (MPO)
- Immune crescentic glomerulonephritis (+ve in 80%)
- Microscopic polyangiitis (+ve in 50-75%)
- Churg-Strauss (+ve in 60%)
- Wegener’s (+ve in 25%)
- Others = IBD (UC > Crohn’s), CTD, Autoimmune hepatitis
Complement Deficiencies?
C1
- Causes hereditary angioedema
C1q, C1rs, C2, C4
- Predisposes to immune complex disease
- SLE, HSP
C3
- Causes recurrent bacterial infections
C5
- Predisposes to Leiner disease
- Recurent diarrhoea, wasting and seborrhoeic dermatitis
- Disseminated meningococcal infection
C5-9
- Encodes for the MAC
- Prone to Neisseria meningitidis infection
Anion gap?
(Na+ + K+) - (Cl- + HCO-3)
Causes of normal anion gap metabolic acidosis (hyperchloraemic)
- Gastrointestinal bicarbonate loss: diarrhea, ureterosigmoidostomy, fistula
- Addison’s disease
- Renal tubular acidosis
- Drugs: e.g. Acetazolamide
- Ammonium chloride injection
GARDA
HCO3 loss and replaced with Cl- -> anion gap normal
Causes of HAGMA?
Accumulation of organic acids or impaired H+ excretion
LKTR
- Lactate - shock, hypoxia
- Ketones - DKA, alcohol
- Toxins - salicyclates, methanol
- Renal - high urea
Lactic acidosis types?
Type A
- Shock, hypoxia, burns
Type B
- Metformin
Causes of metabolic alkalosis?
Loss of hydrogen ions or gain of bicarbonate
- Vomiting / aspiration (e.g. Peptic ulcer leading to pyloric stenosis, nasogastric suction)
- Diuretics
- ECF depletion –> Na+ and Cl- loss –> activation of RAAS –> raised aldosterone –> reabsorption of Na+ in exchange for H+ in DCT
- Liquorice, carbenoxolone
- Hypokalemia - K+ shifts into ECF, H+ shifts into cells to maintain neutrality –> alkalosis
- Primary hyperaldosteronism
- Congenital adrenal hyperplasia
- Cushing’s syndrome
- Bartter’s syndrome
- Defect in thick ascending loop of Henle
- Hypokalaemia, alkalosis, and normal to low blood pressure
Interpretation of urinary sodium in hyponatraemia?
>20mmol/L
- Sodium depletion due to renal loss
- If hypovolaemic
- Diuretics, diuretic stage of renal failure, Addison’s
- If euvolaemic
- SIADH (urine osmolality >500)
- Hypothyroidism
<20mmol/L
- Sodium depletion, extra-renal loss
- If hypovolaemic
- Diarrhoea, vomiting, sweating
- Burns, adenoma of rectum
- If overloaded
- Secondary hyperaldosteronism, CCF, cirrhosis
- Low EGFR with volume overload
- IV dextrose, psychogenic polydipsia
Causes and consequences of hypophosphataemia?
Causes
- Alcohol excess
- Acute liver failure
- Diabetic ketoacidosis
- Refeeding syndrome (like in anorexia nervosa management)
- Primary hyperparathyroidism
- Osteomalacia
Consequences
- Red blood cell hemolysis
- White blood cell and platelet dysfunction
- Muscle weakness and rhabdomyolysis
- Central nervous system dysfunction
Actions of PTH and vitamin D?
PTH
- Increases plasma calcium, Decreases plasma phosphate
- Increases renal tubular reabsorption of calcium
- Increases osteoclastic activity
- Increases renal conversion of 25-hydroxy vitamin D to 1,25 dihydroxy vitamin D
- Decreases renal phosphate reabsorption
Vitamin D
- Increases plasma calcium and Increases plasma phosphate
- Increases renal tubular reabsorption and gut absorption of calcium
- Increases osteoclastic activity
- Increases renal phosphate reabsorption
Causes of hyper and hypocalcaemia?
Hypercalcaemia
- Sarcoidosis
- Vitamin D intoxication
- Acromegaly
- Thyrotoxicosis
- Milk-alkali syndrome
- Drugs: thiazides, Ca++ containing antacids
- Dehydration
- Addison’s disease
- Paget’s disease of bone
Hypocalcaemia
- Vitamin D deficiency (osteomalacia)
- Chronic renal failure
- Hypoparathyroidism (e.g. Post thyroid/parathyroid surgery)
- Pseudohypoparathyroidism (target cells insensitive to PTH)
- Rhabdomyolysis (initial stages)
- Magnesium deficiency (due to end organ PTH resistance)
Hyperuricaemia?
Associated with hyperlipidaemia and HTN - seen in metabolic syndrome
Increased synthesis
- Lesch-Nyhan disease
- Myeloproliferative disorders
- Diet rich in purines
- Exercise
- Psoriasis
- Cytotoxics
Decreased Excretion
- Drugs: low-dose aspirin, diuretics, pyrazinamide
- Pre-eclampsia
- Alcohol
- Renal failure
- Lead
Acute phase reactants and negative acute phase reactants?
Increase
- CRP
- Ferritin
- Fibrinogen
- Alpha-1 antitrypsin
- Caeruloplasmin
- Serum amyloid A
- Serum amyloid P component
- Haptoglobin
- Complement
Decrease
- Albumin
- Transthyretin (formerly known as prealbumin)
- Transferrin
- Retinol binding protein
- Cortisol binding protein
RF - what is it? Conditions with +ve RF?
IgM antibody against own IgG
Detected by
- Rose-Waaler test: sheep red cell agglutination
- Latex agglutination test (less specific)
Conditions
- Sjogren’s syndrome (around 100%)
- Felty’s syndrome (around 100%)
- Infective endocarditis (= 50%)
- SLE (= 20-30%)
- Systemic sclerosis (= 30%)
- General population (= 5%)
- Rarely: TB, HBV, EBV, leprosy
Effects of nitric oxide?
- Acts on guanylate cyclase leading to raised intracellular cGMP levels and therefore decreasing Ca++ levels
- Vasodilation, mainly venodilation
- Inhibits platelet aggregation
Actions of atrial natriuretic peptide?
Secreted by both atria (R>L) and ventricle in response to increased blood volume
Acts via guanylate cyclase and cGMP
- Natriuetic (promotes excretion of sodium)
- Lowers BP
- Antagonises angiotensin II, aldosterone
BNP actions?
Produced by LV in response to strain
- Vasodilator
- Diuretic and natriuretic
- Suppresses both sympathetic tone and the renin-angiotensin-aldosterone system
Useful marker of prognosis in HF, useful in guiding treatment.
Actions of endothelin?
- Potent, long-acting vasoconstrictor and bronchoconstrictor.
- Secreted by vascular endothelium as a prohormone then converted to ET-1 by endothelin converting enzyme.
- Acts via a G-protein coupled receptor –> phospholipase C –> calcium release
Promotes
- Angiotensin II
- ADH
- Hypoxia
- Mechanical shearing forces
Inhibits
- NO
- Prostacyclin
Conditions with raised endothelin levels?
- MI
- Heart failure
- ARF
- Asthma
- Primary pulmonary hypertension (endothelin antagonists now used)
Actions of TNF?
Pro-inflammatory cytokine
Secreted by macrophages
- Activates macrophages and neutrophils
- Acts as a costimulator for T cell activation
- Key mediator of response to gram -ve septicaemia
- Similar properties to IL-1
- Anti-tumour effect (phospholipase activation)
Endothelial and systemic effects of TNF?
Endothelial
- Increased expression of selectins
- Increased production of platelet activating factor, IL-1 and prostaglandins
- Promotes proliferation of fibroblasts and production of protease and collagenase
Systemic
- Pyrexia
- Increased acute phase proteins
- Disordered metabolism leading to cachexia